The clinical utility of biomarkers in asthma and COPD.

Biomarkers with potential utility in the diagnosis and prognosis of asthma and chronic obstructive pulmonary disease (COPD), and in monitoring the natural history of these diseases and the effect of therapeutic interventions, are being widely researched. This review critically describes the methodologies used for obtaining and analysing appropriate biofluid, tissue and exhaled breath samples for biomarker analysis. Currently measurements of sputum eosinophils and exhaled nitric oxide in asthmatics are the best established markers for disease activity and response to anti-inflammatory therapy. Circulating C-reactive protein (CRP) levels have been shown to predict risk of hospitalisation and death from COPD. Biomarker measurements in exhaled breath condensate are the least well-validated techniques. Other assessments in both conditions have potential value in clinical use but require further research and validation.

[1]  R. Kulka,et al.  Exhaled nitric oxide concentration is affected by age, height, and race in healthy 9- to 12-year-old children. , 2008, Chest.

[2]  T. Seemungal,et al.  Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels , 2000, Thrombosis and Haemostasis.

[3]  P. Barnes,et al.  Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[4]  M. Nakamura,et al.  Plasma eotaxin level and severity of asthma treated with corticosteroid. , 2004, Respiratory medicine.

[5]  D. Postma,et al.  Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD , 2000 .

[6]  D. Tashkin,et al.  Exhaled nitric oxide in the assessment of asthma , 2004, Current opinion in pulmonary medicine.

[7]  P. Gibson,et al.  Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma , 2003, Thorax.

[8]  L. Fabbri,et al.  Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. , 1996, Thorax.

[9]  P. Gibson,et al.  The inflammatory response in asthma exacerbation: changes in circulating eosinophils, basophils and their progenitors , 1990, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  A Mutti,et al.  Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults , 2007, European Respiratory Journal.

[11]  A. Torres,et al.  Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[12]  J. Van Damme,et al.  Monocyte chemotactic protein-3. , 2002, European cytokine network.

[13]  J. Cowan,et al.  Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. , 2004, American journal of respiratory and critical care medicine.

[14]  D. Postma,et al.  Effect of ADRB2 polymorphisms on response to longacting β2-agonist therapy: a pharmacogenetic analysis of two randomised studies , 2007, The Lancet.

[15]  B. Balbi,et al.  Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. , 1998, The European respiratory journal.

[16]  T. Almdal,et al.  C-reactive protein--can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease? , 2006, European journal of internal medicine.

[17]  D. Yates,et al.  Nitric Oxide and Exhaled Breath Nitrite/Nitrates in Chronic Obstructive Pulmonary Disease Patients , 2007, Respiration.

[18]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[19]  P. Barnes,et al.  Biomarkers of some pulmonary diseases in exhaled breath , 2002, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[20]  N. Pride,et al.  Exhaled nitric oxide from lung periphery is increased in COPD , 2005, European Respiratory Journal.

[21]  R. Lutter,et al.  Repeatability of Inflammatory Parameters in Induced Sputum of COPD Patients , 2007, COPD.

[22]  P. J. Barnes,et al.  Exhaled breath condensate: methodological recommendations and unresolved questions , 2005, European Respiratory Journal.

[23]  P. Barnes,et al.  Optimized dialysis and protease inhibition of sputum dithiothreitol supernatants. , 2008, American journal of respiratory and critical care medicine.

[24]  I. Pavord,et al.  Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[25]  P. Silkoff,et al.  The relationship of induced-sputum inflammatory cells to BAL and biopsy. , 2003, Chest.

[26]  R. Stockley,et al.  Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). , 1999, American journal of respiratory and critical care medicine.

[27]  B. Nordestgaard,et al.  Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[28]  P. Barnes,et al.  Increased levels of the chemokines GROα and MCP-1 in sputum samples from patients with COPD , 2002, Thorax.

[29]  D. Postma,et al.  Repeated sputum inductions induce a transient neutrophilic and eosinophilic response. , 2006, Chest.

[30]  H. Hammad,et al.  CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment. , 2000, American journal of respiratory and critical care medicine.

[31]  S. Ahlstedt,et al.  Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. , 1995, Thorax.

[32]  I. Pavord,et al.  Biomarkers Predicting Response to Corticosteroid Therapy in Asthma , 2005, Treatments in respiratory medicine.

[33]  Jan Stolk,et al.  Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[34]  F. Hargreave,et al.  Safety of Sputum Induction in Moderate-to-Severe Smoking-Related Chronic Obstructive Pulmonary Disease , 2006, COPD.

[35]  P. Barnes,et al.  Increased inflammatory markers in the exhaled breath condensate of cigarette smokers , 2003, European Respiratory Journal.

[36]  P. Montuschi,et al.  CT-guided pleural biopsy preferable to traditional Abram’s needle in diagnosing malignant pleural disease , 2003, Thorax.

[37]  S. Holgate,et al.  Methods for the assessment of endobronchial biopsies in clinical research: application to studies of pathogenesis and the effects of treatment. , 2003, American journal of respiratory and critical care medicine.

[38]  D. Sin,et al.  Impaired lung function and serum leptin in men and women with normal body weight: a population based study , 2003, Thorax.

[39]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.

[40]  Todor A Popov,et al.  Spontaneous and induced sputum to measure indices of airway inflammation in asthma. , 1996, American journal of respiratory and critical care medicine.

[41]  Richard J Martin,et al.  Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. , 2003, The Journal of pediatrics.

[42]  R. Djukanović,et al.  The relationship between airways inflammation and asthma severity. , 2000, American journal of respiratory and critical care medicine.

[43]  R. Stockley,et al.  Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD , 2001, Thorax.

[44]  N. Borciani,et al.  Neutrophils infiltrating bronchial epithelium in chronic obstructive pulmonary disease. , 1998, Respiratory medicine.

[45]  T. Shimoda,et al.  Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[46]  P. Friedman,et al.  Computed tomographic scan-diagnosed chronic obstructive pulmonary disease-emphysema: eotaxin-1 is associated with bronchodilator response and extent of emphysema. , 2007, The Journal of allergy and clinical immunology.

[47]  M. Pistolesi,et al.  Outcomes for COPD pharmacological trials: from lung function to biomarkers , 2008, European Respiratory Journal.

[48]  P. Panzner,et al.  A critical appraisal of methods used in early clinical development of novel drugs for the treatment of asthma. , 2007, Pulmonary pharmacology & therapeutics.

[49]  J. Wedzicha,et al.  Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[50]  E. Israel,et al.  Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial , 2004, The Lancet.

[51]  J. Marín,et al.  Relationship between induced sputum cell counts and fluid-phase eosinophil cationic protein and clinical or physiologic profiles in mild asthma. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[52]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[53]  A. Agustí,et al.  Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[54]  P. Barnes,et al.  Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD , 2003, Thorax.

[55]  D. Postma,et al.  Assessment of airway inflammation: an overview. , 1998, The European respiratory journal. Supplement.

[56]  I. Tillie‐Leblond,et al.  Characteristics of the Inflammatory Response in Bronchial Lavage Fluids from Patients with Status asthmaticus , 2001, International Archives of Allergy and Immunology.

[57]  N. Zamel,et al.  Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone. , 2001, American journal of respiratory and critical care medicine.

[58]  C. Camargo,et al.  Monocyte Chemotactic Protein‐4 (MCP‐4; CCL‐13): A Biomarker of Asthma , 2004, The Journal of asthma : official journal of the Association for the Care of Asthma.

[59]  I. Sayers,et al.  Pharmacogenetic approaches in the treatment of asthma , 2005, Current allergy and asthma reports.

[60]  V. Siroux,et al.  Relationships of allergic sensitization, total immunoglobulin E and blood eosinophils to asthma severity in children of the EGEA Study , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[61]  L. Fabbri,et al.  Severity of airflow limitation is associated with severity of airway inflammation in smokers. , 1998, American journal of respiratory and critical care medicine.

[62]  F. Dente,et al.  Analysis of Sputum Cell Counts During Spontaneous Moderate Exacerbations of Asthma in Comparison to the Stable Phase , 2003, The Journal of asthma : official journal of the Association for the Care of Asthma.

[63]  R. Sakalauskas,et al.  Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma. , 2007, Respiratory medicine.

[64]  R. Rogers,et al.  Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. , 1996, American journal of respiratory and critical care medicine.

[65]  A. B. Kay,et al.  The role of eosinophils in the pathogenesis of asthma. , 2005, Trends in molecular medicine.

[66]  A Senthilselvan,et al.  Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis , 2004, Thorax.

[67]  N. Zamel,et al.  Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function. , 2001, The European respiratory journal.

[68]  R. Djukanović,et al.  Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD , 2004, Thorax.

[69]  T. Seemungal,et al.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.

[70]  R. Baughman.  Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure. , 2007, Seminars in respiratory and critical care medicine.

[71]  S. Permutt,et al.  Modeling pulmonary nitric oxide exchange. , 2004, Journal of applied physiology.

[72]  M. Corradi,et al.  Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease , 1999, Thorax.

[73]  J. Cowan,et al.  Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. , 2005, The New England journal of medicine.

[74]  L. Fabbri,et al.  Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[75]  K. Chung,et al.  Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma , 2000, Thorax.

[76]  I. Horváth,et al.  Thrombolysis for submassive pulmonary embolism , 2003, Thorax.

[77]  D. Yates,et al.  Collection devices influence the constituents of exhaled breath condensate , 2007, European Respiratory Journal.

[78]  C. Lam,et al.  Increased macrophage‐derived chemokine in exhaled breath condensate and plasma from children with asthma , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[79]  P. Barnes,et al.  Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. , 1997, American journal of respiratory and critical care medicine.

[80]  I. Pavord,et al.  Variability of bronchial inflammation in chronic obstructive pulmonary disease: implications for study design , 2006, European Respiratory Journal.

[81]  L. Fabbri,et al.  Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. , 1995, American journal of respiratory and critical care medicine.

[82]  P. L. Smith,et al.  The hypotonic upper airway in obstructive sleep apnea: role of structures and neuromuscular activity. , 1998, American journal of respiratory and critical care medicine.

[83]  K. Chung,et al.  Neutrophilic inflammation in severe persistent asthma. , 1999, American journal of respiratory and critical care medicine.

[84]  Monya Baker,et al.  In biomarkers we trust? , 2005, Nature Biotechnology.

[85]  Gary Iwamoto,et al.  Exhaled Nitric Oxide Predicts Asthma Exacerbation , 2004, The Journal of asthma : official journal of the Association for the Care of Asthma.

[86]  P. Sterk,et al.  Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal. , 1999, American journal of respiratory and critical care medicine.

[87]  R. Stockley,et al.  The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. , 1999, American journal of respiratory and critical care medicine.

[88]  R. L. Gordon,et al.  The Effects of Age on Exhaled Breath Nitric Oxide Levels , 2006, Lung.

[89]  X. Busquets,et al.  Systemic effects of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[90]  D. Olivieri,et al.  Eotaxin and CCR3 are up‐regulated in exacerbations of chronic bronchitis , 2002, Allergy.

[91]  D. Postma,et al.  Pulmonary biomarkers in chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[92]  P. Barnes,et al.  Optimizing sputum methodology , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[93]  A. Morice,et al.  Breath carbon monoxide as an indication of smoking habit. , 2000, Chest.

[94]  B. Grant,et al.  Airway inflammation and etiology of acute exacerbations of chronic bronchitis. , 2000, Chest.

[95]  Wooten Oj,et al.  Improved homogenization techniques for sputum cytology counts. , 1978 .

[96]  S. Bojesen,et al.  C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. , 2007, American journal of respiratory and critical care medicine.

[97]  E. Melillo,et al.  Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function. , 1999, American journal of respiratory and critical care medicine.

[98]  M. Corradi,et al.  Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[99]  L. Vila,et al.  Eosinophil soluble protein levels, eosinophil peroxidase and eosinophil cationic protein in asthmatic patients. , 1999, Journal of investigational allergology & clinical immunology.

[100]  J. Mege,et al.  Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.

[101]  S. Durham,et al.  CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge , 2004, European Respiratory Journal.

[102]  H. Boezen,et al.  Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies , 2008, European Respiratory Journal.

[103]  W. Koenig,et al.  Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). , 2003, European heart journal.

[104]  L. Fabbri,et al.  Airway eosinophilia in chronic bronchitis during exacerbations. , 1994, American journal of respiratory and critical care medicine.

[105]  R. Djukanović,et al.  The effect of processing on inflammatory markers in induced sputum. , 1999, The European respiratory journal.

[106]  P. Barnes,et al.  CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. , 2008, Chest.

[107]  K. Wright,et al.  Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[108]  R. Lutter,et al.  Analysis of plasma-protein leakage and local secretion in sputum from patients with asthma and chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.

[109]  P. Helms,et al.  Carbonated drink consumption and increased exhaled nitric oxide in atopic children , 2007, European Respiratory Journal.

[110]  R. Stockley,et al.  MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. , 2000, The European respiratory journal.

[111]  P. Gibson,et al.  Clinical Usefulness of Inflammatory Markers in Asthma , 2003, American journal of respiratory medicine : drugs, devices, and other interventions.

[112]  Q. Jöbsis,et al.  Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate , 2006, European Respiratory Journal.

[113]  B. Balbi,et al.  Is dithiothreitol affecting cells and soluble mediators during sputum processing? A modified methodology to process sputum. , 2002, The Journal of allergy and clinical immunology.

[114]  N. Lazzeri,et al.  Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. , 2000, American journal of respiratory and critical care medicine.

[115]  L. Teran,et al.  The monocyte‐derived chemokine is released in the bronchoalveolar lavage fluid of steady‐state asthmatics , 2003, Allergy.

[116]  P. Dargaville,et al.  Validity of markers of dilution in small volume lung lavage. , 1999, American journal of respiratory and critical care medicine.

[117]  W. van Beurden,et al.  Exhaled biomarkers in COPD: their potential role in diagnosis, treatment and prognosis. , 2002, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[118]  S. Hodge,et al.  Increased intracellular T helper 1 proinflammatory cytokine production in peripheral blood, bronchoalveolar lavage and intraepithelial T cells of COPD subjects , 2007, Clinical and experimental immunology.

[119]  A. Ionescu,et al.  Inflammatory response and body composition in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[120]  A. Bodzenta-Lukaszyk,et al.  The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease. , 2005, Respiratory medicine.

[121]  K. Knox,et al.  Bronchoalveolar Lavage as a Research Tool , 2007, Seminars in respiratory and critical care medicine.

[122]  J. Enghild,et al.  Human skin keratins are the major proteins in exhaled breath condensate , 2008, European Respiratory Journal.

[123]  A. Karabulut,et al.  Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. , 2006, Respiratory medicine.

[124]  T. Yoneda,et al.  Airway inflammation in COPD assessed by sputum levels of interleukin-8. , 1997, Chest.

[125]  E. Bacci,et al.  Analysis of induced sputum before and after withdrawal of treatment with inhaled corticosteroids in asthmatic patients , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[126]  R. Stockley,et al.  Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis , 2002, Thorax.

[127]  J. Fahy,et al.  Fractional analysis of sequential induced sputum samples during sputum induction: evidence that different lung compartments are sampled at different time points. , 1999, The Journal of allergy and clinical immunology.

[128]  P. O'Byrne,et al.  Induced sputum cell counts in healthy adults. , 2000, American journal of respiratory and critical care medicine.

[129]  E. Benjamin,et al.  Systemic inflammation and COPD: the Framingham Heart Study. , 2008, Chest.

[130]  Choon-Sik Park,et al.  Association of Interleukin-5 and Eotaxin with Acute Exacerbation of Asthma , 2003, International Archives of Allergy and Immunology.

[131]  P. Sterk,et al.  Standardised methodology of sputum induction and processing , 2002, European Respiratory Journal.

[132]  J. Govan,et al.  Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. , 1998, Respiratory medicine.

[133]  T. Seemungal,et al.  Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease , 2001, Thorax.

[134]  E. Wouters,et al.  Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD. , 2007, Respiratory medicine.

[135]  M. Aubier,et al.  Airway structural alterations selectively associated with severe asthma. , 2003, American journal of respiratory and critical care medicine.

[136]  Meindert Danhof,et al.  Markers of disease severity in chronic obstructive pulmonary disease. , 2006, Pulmonary pharmacology & therapeutics.

[137]  E. Piitulainen,et al.  Analysis of Systemic Biomarkers in COPD Patients , 2004, COPD.

[138]  Stephen T Holgate,et al.  Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. , 2004, American journal of respiratory and critical care medicine.

[139]  I. Pavord,et al.  The influence of age on induced sputum differential cell counts in normal subjects. , 2004, Chest.

[140]  E. Grebski,et al.  Effect of physical and chemical methods of homogenization on inflammatory mediators in sputum of asthma patients. , 2001, Chest.

[141]  W. Busse,et al.  Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced asthma. , 2004, American journal of respiratory and critical care medicine.

[142]  P. Sterk,et al.  Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. , 1996, The European respiratory journal.

[143]  H. Saito,et al.  The Relationship between Chronic Hypoxemia and Activation of the Tumor Necrosis Factor- α System in Patients with Chronic Obstructive Pulmonary Disease , 2000 .

[144]  L. Corbetta,et al.  Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[145]  N. Chavannes,et al.  Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. , 2002, American journal of respiratory and critical care medicine.

[146]  I. Pavord,et al.  Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial , 2007, European Respiratory Journal.

[147]  T. Seemungal,et al.  Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease , 1998, Thorax.

[148]  C. Bachert,et al.  Soluble Interleukin-5 Receptor Alpha Is Increased in Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 2004, International Archives of Allergy and Immunology.

[149]  F. García-Río,et al.  Relationship Between Exhaled Carbon Monoxide and Airway Hyperresponsiveness in Asthmatic Patients , 2004, The Journal of asthma : official journal of the Association for the Care of Asthma.

[150]  A. James,et al.  The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. , 1997, The European respiratory journal.

[151]  P. Barnes,et al.  High levels of interleukin-6 in the exhaled breath condensate of patients with COPD. , 2003, Respiratory medicine.

[152]  R. Stockley,et al.  Validation of assays for inflammatory mediators in sputum. , 2000, The European respiratory journal.

[153]  P. Barnes,et al.  Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children , 2003, European Respiratory Journal.

[154]  E. Wouters,et al.  Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations , 2001, Thorax.

[155]  M. Rinaldi,et al.  Serum ECP and MPO are increased during exacerbations of chronic bronchitis with airway obstruction. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[156]  R. Atmar,et al.  Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[157]  K. Chung,et al.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.

[158]  W. Maziak,et al.  Exhaled nitric oxide in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[159]  W. Lumry,et al.  Omalizumab is effective in the long-term control of severe allergic asthma. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[160]  R. Stockley,et al.  The chemotactic activity of sputum from patients with bronchiectasis. , 1998, American journal of respiratory and critical care medicine.

[161]  X. Busquets,et al.  Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[162]  Q. Hamid,et al.  Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. , 1997, Journal of immunology.

[163]  I. Adcock,et al.  Loss of control of asthma following inhaled corticosteroid withdrawal is associated with increased sputum interleukin-8 and neutrophils. , 2007, Chest.

[164]  H. Magnussen,et al.  In patients with chronic bronchitis a four week trial with inhaled steroids does not attenuate airway inflammation. , 2001, Respiratory medicine.

[165]  N. Siafakas,et al.  Induced sputum CD8+ T-lymphocyte subpopulations in chronic obstructive pulmonary disease. , 2004, Respiratory medicine.